Previous studies in colon, bladder, and endometrial cancers also provided evidences that biglycan promotes cancer cell migration, invasion [21,23,51], and proliferation, which ultimately result in increased resistance to 5-fluorouracil chemotherapy [52]. The gene discussed is BGN; the disease is endometrial cancer.